Vittorio Nisita
Corporate Officer/Principal chez ORGANON & CO.
Fortune : 395 157 $ au 31/03/2024
Profil
Vittorio Nisita is currently the Head-Global Business Services at Organon & Co. He previously worked as a Vice President at Merck Sharp & Dohme Corp.
Nisita received his undergraduate degree from the University of Minnesota and his MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ORGANON & CO.
0,01% | 31/03/2024 | 21 019 ( 0,01% ) | 395 157 $ | 31/03/2024 |
Postes actifs de Vittorio Nisita
| Sociétés | Poste | Début |
|---|---|---|
| ORGANON & CO. | Corporate Officer/Principal | 02/06/2021 |
Anciens postes connus de Vittorio Nisita
| Sociétés | Poste | Fin |
|---|---|---|
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Corporate Officer/Principal | - |
Formation de Vittorio Nisita
| University of Minnesota | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORGANON & CO. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Health Technology |
